Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McGill University

$360,316.00

Improving cardiovascular disease risk factors in individuals with PCOS using exogenous ketone monoester ingestion

EF 2022-23

Résumé
People with polycystic ovary syndrome (PCOS) are at an increased risk for developing cardiovascular diseases. Although this disorder affects approximately 1 in 5 females in Canada, effective treatments to improve cardiovascular health in PCOS are lacking. Oral ketone body supplements have been shown to improve outcomes related to cardiovascular health in obese, pre-diabetic, diabetic, and heart failure patients. While they have not yet been tested in individuals with PCOS, ketone supplements have potential to improve cardiovascular health in individuals with PCOS. Therefore, the purpose of this study is to examine whether ketone supplements are effective in improving outcomes related to cardiovascular health in individuals with PCOS. On two different days, we will ask individuals with PCOS to consume a beverage containing a ketone supplement and a beverage containing a placebo supplement. We will then compare outcomes related to cardiovascular health between ketone and placebo days in order to measure the improvements mediated by ketones versus placebo. Given that cardiovascular diseases are the second leading cause of death for females in Canada, we require effective interventions to improve cardiovascular health in females predisposed to cardiovascular diseases. This study will test the effectiveness of a simple, safe, well-tolerated, and commercially-available treatment for individuals with PCOS which demonstrates promise to improve cardiovascular health outcomes in this vulnerable population.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
479126
Name
Usselman Charlotte W
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Improving cardiovascular disease risk factors in individuals with PCOS using exogenous ketone monoester ingestion
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$360,316
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Blood Pressure; Cold Pressor Test; Endothelial Function; Flow Mediated Dilation; Handgrip Exercise; Insulin Resistance; Ketone Monoester Ingestion; Neurovascular Transduction; Oral Glucose Tolerance Test; Polycystic Ovary Syndrome
Abstract
People with polycystic ovary syndrome (PCOS) are at an increased risk for developing cardiovascular diseases. Although this disorder affects approximately 1 in 5 females in Canada, effective treatments to improve cardiovascular health in PCOS are lacking. Oral ketone body supplements have been shown to improve outcomes related to cardiovascular health in obese, pre-diabetic, diabetic, and heart failure patients. While they have not yet been tested in individuals with PCOS, ketone supplements have potential to improve cardiovascular health in individuals with PCOS. Therefore, the purpose of this study is to examine whether ketone supplements are effective in improving outcomes related to cardiovascular health in individuals with PCOS. On two different days, we will ask individuals with PCOS to consume a beverage containing a ketone supplement and a beverage containing a placebo supplement. We will then compare outcomes related to cardiovascular health between ketone and placebo days in order to measure the improvements mediated by ketones versus placebo. Given that cardiovascular diseases are the second leading cause of death for females in Canada, we require effective interventions to improve cardiovascular health in females predisposed to cardiovascular diseases. This study will test the effectiveness of a simple, safe, well-tolerated, and commercially-available treatment for individuals with PCOS which demonstrates promise to improve cardiovascular health outcomes in this vulnerable population.
Competitiondate
202303
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Usselman, Charlotte W
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $360,316~ $0~